These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31881062)
1. NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis. Wei Z; Zhang M; Zhang X; Yi M; Xia X; Fang X PLoS One; 2019; 14(12):e0227043. PubMed ID: 31881062 [TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies. Song Y; Qi X; Liu X Gene; 2020 Oct; 757():144924. PubMed ID: 32622992 [TBL] [Abstract][Full Text] [Related]
3. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012 [TBL] [Abstract][Full Text] [Related]
4. An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians. Balaji L; Krishna BS; Bhaskar LV Arch Oral Biol; 2012 May; 57(5):513-8. PubMed ID: 22137356 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Hein DW; Doll MA Pharmacogenomics; 2012 Jan; 13(1):31-41. PubMed ID: 22092036 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis. Tian FS; Shen L; Ren YW; Zhang Y; Yin ZH; Zhou BS Asian Pac J Cancer Prev; 2014; 15(14):5621-6. PubMed ID: 25081676 [TBL] [Abstract][Full Text] [Related]
7. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group. Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356 [TBL] [Abstract][Full Text] [Related]
8. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients. Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660 [TBL] [Abstract][Full Text] [Related]
9. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population. Deguchi M; Yoshida S; Kennedy S; Ohara N; Motoyama S; Maruo T J Soc Gynecol Investig; 2005 Apr; 12(3):208-13. PubMed ID: 15784508 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups. Suarez-Kurtz G; Fuchshuber-Moraes M; Struchiner CJ; Parra EJ Pharmacogenet Genomics; 2016 Aug; 26(8):363-9. PubMed ID: 27136043 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study. Zou Y; Dong S; Xu S; Gong Q; Chen J Medicine (Baltimore); 2017 Oct; 96(42):e7499. PubMed ID: 29049179 [TBL] [Abstract][Full Text] [Related]
12. Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis. Zhu X; Liu Y; Chen G; Guo Q; Zhang Z; Zhao L; Wei R; Yin X; Zhang Y; Wang B; Li X Medicine (Baltimore); 2019 Mar; 98(12):e14942. PubMed ID: 30896661 [TBL] [Abstract][Full Text] [Related]
13. [Genotype and phenotype polymorphisms of NAT2 and CYP2E1 in the Han Chinese pediatric population]. Liu F; Miao Q; Jiao WW; Xiao J; Sun L; Shen C; Wu XR; Shen D; Yin QQ; Shen AD Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):353-8. PubMed ID: 22613106 [TBL] [Abstract][Full Text] [Related]
14. Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility. Liu C; Cui W; Cong L; Wang L; Ruan X; Jia J; Liu Y; Jia X; Zhang X Medicine (Baltimore); 2015 Dec; 94(49):e1947. PubMed ID: 26656326 [TBL] [Abstract][Full Text] [Related]
15. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population. Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070 [TBL] [Abstract][Full Text] [Related]
16. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301 [TBL] [Abstract][Full Text] [Related]
17. Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients. Levano KS; Jaramillo-Valverde L; Tarazona DD; Sanchez C; Capristano S; Vásquez-Loarte T; Solari L; Mendoza-Ticona A; Soto A; Rojas C; Zegarra-Chapoñan R; Guio H Mol Genet Genomic Med; 2021 Oct; 9(10):e1764. PubMed ID: 34510815 [TBL] [Abstract][Full Text] [Related]
18. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196 [TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population. Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831 [TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study. Adole PS; Kharbanda PS; Sharma S Indian J Med Res; 2016 May; 143(5):581-90. PubMed ID: 27488001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]